ASCENDIS PHARMA A S's ticker is and the CUSIP is 04351P951. A total of 4 filers reported holding ASCENDIS PHARMA A S in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,301,972 | +34.0% | 67,300 | +27.7% | 0.00% | 0.0% |
| Q2 2023 | $4,703,475 | +7.8% | 52,700 | +29.5% | 0.00% | 0.0% |
| Q1 2023 | $4,363,854 | +16.8% | 40,700 | +33.0% | 0.00% | 0.0% |
| Q4 2022 | $3,737,178 | +109.2% | 30,600 | +76.9% | 0.00% | +100.0% |
| Q3 2022 | $1,786,000 | -47.8% | 17,300 | -53.0% | 0.00% | 0.0% |
| Q2 2022 | $3,421,000 | – | 36,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 12,300 | $1,151,772 | 0.00% |
| JANE STREET GROUP, LLC | 67,300 | $6,301,972 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 25,000 | $2,341,000 | 0.00% |
| SIMPLEX TRADING, LLC | 3,400 | $318 | 0.00% |